HNC |
Head and Neck cancers |
SCC |
squamous cell carcinomas |
HNSCC |
Head and neck squamous cell carcinomas |
ECM |
Extracellular matrix |
LN-111 |
Laminin subtype 111 |
LN-332 |
Laminin subtype 332 |
BM |
Basement membrane |
EGF |
Epidermal-growth factor |
EGFR |
Epidermal-growth factor |
MAPK |
Mitogen-activated protein kinase |
HPV |
Human papiloma virus |
EBV |
Epstein Barr Virus |
PI3K |
Phosphoinositide 3-kinase |
OCSCC |
Oral cavity squamous cell carcinomas |
MMP-2 |
matrix metalloproteinase 2 |
MT1-MMP |
membrane type 1 matrix metalloproteinase |
EMT |
epithelial–mesenchymal transition |
DIII |
γ2 chain fragment |
TSCC |
tongue squamous cell carcinoma |
AKT |
Protein kinase B |
RNA |
Ribonucleic acid |
MMP-9 |
matrix metalloproteinase 9 |
Src |
Proto-oncogene tyrosine-protein kinase Src |
ERK 1/2 |
Extracellular signal-regulated kinases 1 and 2 |
OPSCC |
oropharyngeal squamous cell carcinomas |
NPSCC |
nasopharyngeal squamous cell carcinomas |
LMP1, 2a and 2b |
Latent membrane proteins 1, 2a and 2b |
LAMC2 |
gene that encodes the γ2 chain |
HPSCC |
hypopharyngeal squamous cell carcinomas |
IL-6 |
Interleukin 6 |
LSCC |
Laryngeal squamous cell carcinomas |
CIS |
in situ squamous epithelial carcinomas |
LR |
Laminin receptor |
SSCC |
Skin squamous cell carcinomas |
LRP |
Laminin receptor precursor |